Myomo Future Growth
Future criteria checks 5/6
Myomo is forecast to grow earnings and revenue by 70.3% and 22.4% per annum respectively while EPS is expected to grow by 70.2% per annum.
Key information
70.3%
Earnings growth rate
70.2%
EPS growth rate
| Medical Equipment earnings growth | 14.7% |
| Revenue growth rate | 22.4% |
| Future return on equity | n/a |
| Analyst coverage | Good |
| Last updated | 07 Nov 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 49 | 9 | N/A | N/A | 2 |
| 12/31/2025 | 41 | -2 | -3 | -1 | 5 |
| 12/31/2024 | 30 | -7 | -8 | -6 | 5 |
| 9/30/2024 | 25 | -8 | -10 | -9 | N/A |
| 6/30/2024 | 21 | -9 | -9 | -9 | N/A |
| 3/31/2024 | 20 | -9 | -8 | -8 | N/A |
| 12/31/2023 | 19 | -8 | -6 | -6 | N/A |
| 9/30/2023 | 19 | -8 | -6 | -6 | N/A |
| 6/30/2023 | 17 | -9 | -7 | -7 | N/A |
| 3/31/2023 | 15 | -11 | -10 | -10 | N/A |
| 12/31/2022 | 16 | -11 | -10 | -10 | N/A |
| 9/30/2022 | 16 | -12 | -10 | -10 | N/A |
| 6/30/2022 | 16 | -11 | -9 | -9 | N/A |
| 3/31/2022 | 15 | -11 | -10 | -10 | N/A |
| 12/31/2021 | 14 | -11 | -10 | -10 | N/A |
| 9/30/2021 | 14 | -9 | -9 | -9 | N/A |
| 6/30/2021 | 11 | -10 | -9 | -8 | N/A |
| 3/31/2021 | 9 | -11 | -9 | -9 | N/A |
| 12/31/2020 | 8 | -12 | -9 | -9 | N/A |
| 9/30/2020 | 5 | -13 | -11 | -11 | N/A |
| 6/30/2020 | 4 | -13 | -11 | -11 | N/A |
| 3/31/2020 | 4 | -13 | -10 | -10 | N/A |
| 12/31/2019 | 4 | -12 | -10 | -10 | N/A |
| 9/30/2019 | 3 | -11 | -10 | -10 | N/A |
| 6/30/2019 | 3 | -11 | -10 | -10 | N/A |
| 3/31/2019 | 3 | -11 | -11 | -10 | N/A |
| 12/31/2018 | 2 | -10 | -10 | -10 | N/A |
| 9/30/2018 | 2 | -10 | -9 | -9 | N/A |
| 6/30/2018 | 2 | -8 | N/A | -8 | N/A |
| 3/31/2018 | 2 | -13 | N/A | -7 | N/A |
| 12/31/2017 | 2 | -13 | N/A | -6 | N/A |
| 9/30/2017 | 1 | -12 | N/A | -6 | N/A |
| 6/30/2017 | 1 | -12 | N/A | -5 | N/A |
| 3/31/2017 | 1 | -5 | N/A | -4 | N/A |
| 12/31/2016 | 1 | -4 | N/A | -3 | N/A |
| 9/30/2016 | 1 | -4 | N/A | -3 | N/A |
| 6/30/2016 | 1 | -4 | N/A | -3 | N/A |
| 3/31/2016 | 1 | -4 | N/A | -3 | N/A |
| 12/31/2015 | 1 | -4 | N/A | -3 | N/A |
| 12/31/2014 | 1 | -4 | N/A | -3 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 0M61 is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (1%).
Earnings vs Market: 0M61 is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: 0M61 is expected to become profitable in the next 3 years.
Revenue vs Market: 0M61's revenue (22.4% per year) is forecast to grow faster than the German market (5.6% per year).
High Growth Revenue: 0M61's revenue (22.4% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 0M61's Return on Equity is forecast to be high in 3 years time